Regulation of P-glycoprotein and Other ABC Drug Transporters at the Blood-brain Barrier

Overview

Journal Trends Pharmacol Sci

Specialty Pharmacology

Date 2010 Apr 27

PMID 20417575

Citations 148

Authors

David S Miller

Affiliations

Soon will be listed here.

Abstract

ATP-binding cassette (ABC) transporters are important selective elements of the blood-brain barrier. They line the luminal plasma membrane of the brain capillary endothelium, facing the vascular space, and both protect the central nervous system from entry of neurotoxicants and limit the access of therapeutic drugs to the brain parenchyma. Recent studies highlight the multiple signaling pathways through which the expression and activity of P-glycoprotein and other ABC transporters are modulated in response to xenobiotics, stress and disease. The results show that increased transporter expression occurs in response to signals that activate specific transcription factors, including pregnane-X receptor, constitutive androstane receptor, nuclear factor-kappaB and activator protein-1, and that reduced transporter activity occurs rapidly and reversibly in response to signaling through Src kinase, protein kinase C and estrogen receptors. A detailed understanding of such regulation can provide the basis for improved neuroprotection and enhanced therapeutic drug delivery to the brain.

Citing Articles

Omega-3 Polyunsaturated Fatty Acids and Blood-Brain Barrier Integrity in Major Depressive Disorder: Restoring Balance for Neuroinflammation and Neuroprotection.

Zailani H, Wang W, Satyanarayanan S, Chiu W, Liu W, Sung Y Yale J Biol Med. 2024; 97(3):349-363.

PMID: 39351324 PMC: 11426295. DOI: 10.59249/YZLQ4631.

Cryo-EM reveals a phosphorylated R-domain envelops the NBD1 catalytic domain in an ABC transporter.

Souza Amado de Carvalho R, Rasel M, Khandelwal N, Tomasiak T Life Sci Alliance. 2024; 7(11).

PMID: 39209537 PMC: 11361370. DOI: 10.26508/lsa.202402779.

Comparative CNS Pharmacology of the Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating Multiple Sclerosis.

Turner T, Brun P, Gruber R, Ofengeim D Drugs R D. 2024; 24(2):263-274.

PMID: 38965189 PMC: 11315827. DOI: 10.1007/s40268-024-00468-4.

Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System.

Villa M, Wu J, Hansen S, Pahnke J Cells. 2024; 13(9.

PMID: 38727275 PMC: 11083179. DOI: 10.3390/cells13090740.

Electroacupuncture stimulation enhances the permeability of the blood-brain barrier: A systematic review and meta-analysis of preclinical evidence and possible mechanisms.

Xu N, Gong P, Xu S, Chen Y, Dai M, Jia Z PLoS One. 2024; 19(3):e0298533.

PMID: 38536776 PMC: 10971611. DOI: 10.1371/journal.pone.0298533.

References

Abbott N, Patabendige A, Dolman D, Yusof S, Begley D . Structure and function of the blood-brain barrier. Neurobiol Dis. 2009; 37(1):13-25. DOI: 10.1016/j.nbd.2009.07.030. View

Block M, Wu X, Pei Z, Li G, Wang T, Qin L . Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J. 2004; 18(13):1618-20. DOI: 10.1096/fj.04-1945fje. View

Breedveld P, Beijnen J, Schellens J . Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends Pharmacol Sci. 2005; 27(1):17-24. DOI: 10.1016/j.tips.2005.11.009. View

Calderon-Garciduenas L, Franco-Lira M, Torres-Jardon R, Henriquez-Roldan C, Barragan-Mejia G, Valencia-Salazar G . Pediatric respiratory and systemic effects of chronic air pollution exposure: nose, lung, heart, and brain pathology. Toxicol Pathol. 2007; 35(1):154-62. DOI: 10.1080/01926230601059985. View

Hawkins B, Sykes D, Miller D . Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor. J Neurosci. 2010; 30(4):1417-25. PMC: 2830816. DOI: 10.1523/JNEUROSCI.5103-09.2010. View

Baltes S, Gastens A, Fedrowitz M, Potschka H, Kaever V, Loscher W . Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology. 2006; 52(2):333-46. DOI: 10.1016/j.neuropharm.2006.07.038. View

Leslie E, Deeley R, Cole S . Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology. 2001; 167(1):3-23. DOI: 10.1016/s0300-483x(01)00454-1. View

Barakat S, Turcotte S, Demeule M, Lachambre M, Regina A, Baggetto L . Regulation of brain endothelial cells migration and angiogenesis by P-glycoprotein/caveolin-1 interaction. Biochem Biophys Res Commun. 2008; 372(3):440-6. DOI: 10.1016/j.bbrc.2008.05.012. View

Hawkins B, Davis T . The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57(2):173-85. DOI: 10.1124/pr.57.2.4. View

10.

Sills G, Mohanraj R, Butler E, McCrindle S, Collier L, Wilson E . Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia. 2005; 46(5):643-7. DOI: 10.1111/j.1528-1167.2005.46304.x. View

11.

Hayashi K, Pu H, Andras I, Eum S, Yamauchi A, Hennig B . HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier. J Cereb Blood Flow Metab. 2006; 26(8):1052-65. DOI: 10.1038/sj.jcbfm.9600254. View

12.

Bauer B, Hartz A, Fricker G, Miller D . Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol. 2004; 66(3):413-9. DOI: 10.1124/mol.66.3.. View

13.

Teng S, Piquette-Miller M . Regulation of transporters by nuclear hormone receptors: implications during inflammation. Mol Pharm. 2007; 5(1):67-76. DOI: 10.1021/mp700102q. View

14.

Seelbach M, Brooks T, Egleton R, Davis T . Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein. J Neurochem. 2007; 102(5):1677-1690. DOI: 10.1111/j.1471-4159.2007.04644.x. View

15.

Kemper E, Verheij M, Boogerd W, Beijnen J, van Tellingen O . Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein. Eur J Cancer. 2004; 40(8):1269-74. DOI: 10.1016/j.ejca.2004.01.024. View

16.

Rigor R, Hawkins B, Miller D . Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain. J Cereb Blood Flow Metab. 2010; 30(7):1373-83. PMC: 2949219. DOI: 10.1038/jcbfm.2010.21. View

17.

Narang V, Fraga C, Kumar N, Shen J, Throm S, Stewart C . Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. Am J Physiol Cell Physiol. 2008; 295(2):C440-50. PMC: 2518425. DOI: 10.1152/ajpcell.00491.2007. View

18.

Dallas S, Miller D, Bendayan R . Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol Rev. 2006; 58(2):140-61. DOI: 10.1124/pr.58.2.3. View

19.

Hartz A, Bauer B, Block M, Hong J, Miller D . Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. FASEB J. 2008; 22(8):2723-33. PMC: 2493447. DOI: 10.1096/fj.08-106997. View

20.

Anderson G, Shen D . Where is the evidence that p-glycoprotein limits brain uptake of antiepileptic drug and contributes to drug resistance in epilepsy?. Epilepsia. 2007; 48(12):2372-4. DOI: 10.1111/j.1528-1167.2007.01260_3.x. View